questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact on patients with (a) Addison's Disease and (b) adrenal insufficiency of the permanent discontinuation of hydrocortisone sodium phosphate 100mg/1ml solution by Advanz Pharma.
answerText: The Department are aware of the discontinuation of hydrocortisone sodium phosphate 100 milligram/one millilitre solution for injection and we continue to work with industry to find a longer-term solution.Hydrocortisone sodium succinate 100 milligram powde...
heading: Hydrocortisone